Xiaohan Yao

1.4k total citations
40 papers, 936 citations indexed

About

Xiaohan Yao is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xiaohan Yao has authored 40 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Immunology. Recurrent topics in Xiaohan Yao's work include MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (5 papers) and Immune cells in cancer (5 papers). Xiaohan Yao is often cited by papers focused on MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (5 papers) and Immune cells in cancer (5 papers). Xiaohan Yao collaborates with scholars based in China, United States and Germany. Xiaohan Yao's co-authors include Zhihai Qin, Jiajia Wan, Xixi Duan, Ming Wang, Xiaohan Lou, Yanqiong Zeng, Jianru Li, Yan Yan, Chunli Zhou and Yi Liu and has published in prestigious journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaohan Yao

39 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohan Yao China 17 499 213 194 140 128 40 936
Xiaojun Xu China 18 416 0.8× 132 0.6× 189 1.0× 105 0.8× 153 1.2× 65 1.1k
Xiaoyan Fan China 17 713 1.4× 302 1.4× 204 1.1× 144 1.0× 269 2.1× 32 1.1k
Eva Hamade Lebanon 19 532 1.1× 331 1.6× 159 0.8× 78 0.6× 73 0.6× 50 1.2k
Xiaoxia Yang China 16 590 1.2× 352 1.7× 287 1.5× 65 0.5× 155 1.2× 44 1.2k
Chao Feng China 19 512 1.0× 197 0.9× 175 0.9× 66 0.5× 143 1.1× 61 1.1k
Emma Guilbaud United States 8 444 0.9× 91 0.4× 299 1.5× 121 0.9× 150 1.2× 18 968
Yu Jin Lee South Korea 17 786 1.6× 289 1.4× 110 0.6× 66 0.5× 143 1.1× 36 1.3k
Jing Ma China 18 428 0.9× 163 0.8× 306 1.6× 55 0.4× 94 0.7× 67 1.2k
Qiang Zhu China 19 604 1.2× 174 0.8× 324 1.7× 54 0.4× 137 1.1× 74 1.2k

Countries citing papers authored by Xiaohan Yao

Since Specialization
Citations

This map shows the geographic impact of Xiaohan Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohan Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohan Yao more than expected).

Fields of papers citing papers by Xiaohan Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohan Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohan Yao. The network helps show where Xiaohan Yao may publish in the future.

Co-authorship network of co-authors of Xiaohan Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohan Yao. A scholar is included among the top collaborators of Xiaohan Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohan Yao. Xiaohan Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fazhan, Xiaohan Lou, Fang Wu, et al.. (2025). A Spleen‐Targeted Tolerogenic mRNA‐LNPs Vaccine for the Treatment of Experimental Asthma. Advanced Science. 12(13). e2412543–e2412543. 9 indexed citations
2.
Zhang, Meng, Shouying Du, Xiaohan Yao, et al.. (2025). Engineering a spleen-selective mRNA-LNPs vaccine by decoupling the inflammation from cellular immunity-mediated cancer immunotherapy. Theranostics. 15(18). 9643–9662.
3.
Chen, Ni, Yuanyuan Yang, Wentao Liu, et al.. (2025). Single-cell transcriptomic analysis reveals prognosis-related stromal signatures that potentiate stratification of patients with extrahepatic cholangiocarcinoma. BMC Gastroenterology. 25(1). 235–235. 1 indexed citations
4.
Yao, Xiaohan, et al.. (2024). Parallel CNN-BiLSTM Fault Diagnosis Method Based on Multi-domain Transformation. 42–46. 1 indexed citations
5.
Li, Xia, et al.. (2024). The effect of argatroban on early neurological deterioration and outcomes in minor ischemic stroke: preliminary findings. Frontiers in Neurology. 15. 1363358–1363358. 1 indexed citations
6.
Hu, Yu, Xiaohan Lou, Kaili Zhang, et al.. (2024). Tumor necrosis factor receptor 2 promotes endothelial cell-mediated suppression of CD8+ T cells through tuning glycolysis in chemoresistance of breast cancer. Journal of Translational Medicine. 22(1). 672–672. 5 indexed citations
7.
Wang, Ruirui, Ni Chen, Xiaohan Lou, et al.. (2023). IFNγ blockade in capillary leak site improves tumour chemotherapy by inhibiting lactate-induced endocytosis of vascular endothelial-cadherins. International Journal of Biological Sciences. 19(5). 1490–1508. 4 indexed citations
8.
Zhang, Lijing, Xiaohan Lou, Yangyang Liu, et al.. (2023). Spleen-selective co-delivery of mRNA and TLR4 agonist-loaded LNPs for synergistic immunostimulation and Th1 immune responses. Journal of Controlled Release. 357. 133–148. 53 indexed citations
9.
Cole, Andrew J., Adolfo O. Fumega, Xiaohan Yao, et al.. (2023). Extreme sensitivity of the magnetic ground state to halide composition in FeCl3xBrx. Physical Review Materials. 7(6). 6 indexed citations
10.
Li, Yongjuan, Ningjing Lei, Xiaohan Yao, et al.. (2023). Hijacking Endogenous Iron and GSH Via a Polyvalent Ferroptosis Agonist to Enhance Tumor Immunotherapy. Advanced Functional Materials. 33(44). 20 indexed citations
11.
Li, Wenqing, Yan Yan, Xiaohan Yao, et al.. (2023). MiR-3960 inhibits bladder cancer progression via targeting of DEXI. Biochemical and Biophysical Research Communications. 668. 8–18. 6 indexed citations
12.
Cao, Hong, Ni Chen, Ruoqi Wang, et al.. (2022). Claudin-12 Deficiency Inhibits Tumor Growth by Impairing Transendothelial Migration of Myeloid-Derived Suppressor Cells. Cancer Research. 82(13). 2472–2484. 7 indexed citations
13.
Chen, Ni, Xiaohan Lou, Xiaohan Yao, et al.. (2022). ZIP1+ fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn2+ transfer. Nature Communications. 13(1). 5919–5919. 22 indexed citations
14.
Zhang, Li, Linyu Zhu, Xiaohan Yao, et al.. (2022). Paclitaxel treatment enhances lymphatic metastasis of B16F10 melanoma cells via CCL21/CCR7 axis. International Journal of Biological Sciences. 18(4). 1476–1490. 13 indexed citations
15.
Wang, Ming, Zhongyu Qin, Jiajia Wan, et al.. (2022). Tumor-derived exosomes drive pre-metastatic niche formation in lung via modulating CCL1+ fibroblast and CCR8+ Treg cell interactions. Cancer Immunology Immunotherapy. 71(11). 2717–2730. 63 indexed citations
16.
Wang, Yuanyuan, Yanqiong Zeng, Linyu Zhu, et al.. (2021). Polysaccharides From Lentinus Edodes Inhibits Lymphangiogenesis via the Toll-Like Receptor 4/JNK Pathway of Cancer-Associated Fibroblasts. Frontiers in Oncology. 10. 547683–547683. 18 indexed citations
17.
Wang, Yucheng, Xiaohan Yao, Mei Ma, et al.. (2021). miR-130b inhibits proliferation and promotes differentiation in myocytes via targeting Sp1. Journal of Molecular Cell Biology. 13(6). 422–432. 9 indexed citations
18.
19.
Wang, Yuan, Haiyang Liu, Yangyang Bian, et al.. (2020). Low SCRIB expression in fibroblasts promotes invasion of lung cancer cells. Life Sciences. 256. 117955–117955. 9 indexed citations
20.
Liu, Xiaomeng, Linyu Zhu, Ruirui Wang, et al.. (2019). IFNγ inhibits fibroblast-leading tumor cell invasion through downregulating N-cadherin. Biochemical and Biophysical Research Communications. 512(3). 544–551. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026